Dec 25 2022

CBD-Antibiotic Inhibits Salmonella Growth, According to New Study

An interesting new study  published in the peer-reviewed journal Microorganisms has found that low-doses of CBD inhibits the growth of Salmonella typhimurium.

Salmonella typhimurium illustration.

Salmonella Typhimurium is one of the most common and prevalent foodborne pathogens worldwide leading to diarrhea, vomiting, fever, and abdominal cramps. Effecting up to 1.3 million people each year with over 400 annual deaths in the U.S., the infection often results in hospitalization (an average of 26,500 a year).

For this new study researchers “utilized fluorescence microscopy, biological assays, and bacterial growth kinetics to determine the effectiveness of CBD-broad-spectrum antibiotic co-therapy against S. typhimurium.”
Continue reading

Dec 23 2022

Arkansas: $251 Million in Medical Marijuana (45,677 Pounds) Sold This Year, $29.4 Million in Taxes Garnered

According to new data released by state officials, there was over a quarter of a billion dollars worth of medical marijuana and medical marijuana products sold in the state so far in 2022.

According to the Arkansas Department of Finance and Administration, medical marijuana patients spent $23.2 million on medical marijuana in November. In total patients purchased 4,489 pounds of medical marijuana from 38 dispensaries. This brings the total between January, 2022 and November to $251 million spent on 45,677 pounds of medical marijuana

“Medical marijuana card holders have spent $251.7 million in 2022 to obtain 45,677 pounds,” says Scott Hardin, spokesperson for the Arkansas Department of Finance and Administration “This will certainly be the largest year for sales since the industry launched in 2019.”
Continue reading

Dec 22 2022

Study Finds Cannabidiol May Be a Valuable Tool in Treating Pain From Digital Ulcers

A study published in the most recent issue of the journal Advances in Skin & Wound Care has found that topical CBD “may be a valuable tool to treat pain related to digital ulcers in patients with systemic sclerosis.”

A digital ulcer is a break in the skin of a finger or toe, which can be extremely painful and can become infected. The objective of this new study was to “explore the effect of topical cannabidiol (CBD) in treating digital ulcers in patients with systemic sclerosis (SSc).”

 In total, 45 patients with SSc who had digital ulcers were consecutively enrolled between January 2019 and December 2019. Of the participants, 25 were treated with CBD during surgical debridement and 20 were treated with standard local therapy. A numeric rating scale for pain and Health Assessment Questionnaire Disability Index were administered at the baseline and at the end of treatment.
Continue reading

Dec 22 2022

Automatic Marijuana Expungements Passed Unanimously By D.C. Council

A criminal justice reform bill that includes a provision for the automatic expungement of marijuana charges has been passed in a unanimous vote by the Washington D.C. Council.

The Second Chance Amendment Act was passed by the council by a vote of 13 to 0. This sends the proposal to Mayor Muriel Bowser, who is expected to quickly sign the measure into law.

The act initially stated that a criminal charge for the simple possession of up to two ounces of marijuana would be automatically expunged by the court from people’s records. However, the council approved an amendment by Councilmember Christina Henderson to change the two ounce limit to include “any quantity of marijuana”.
Continue reading

Dec 21 2022

Vermont: $2.6 Million in Marijuana Sold in First Month of Legal Sales, $520,000 in New Taxes

In Vermont’s first month of legal marijuana sales consumers purchased $2.6 million worth of marijuana and marijuana products.

Although Vermont legalized marijuana in October, 2020 following the govern signing Senate Bill 54, the first legal marijuana sales taking place at licensed retail outlets didn’t begin until October of this year.

Now, we have the first data on the state’s legal marijuana market. According to data released by the state’s state Department of Taxes, $2.6 million in marijuana was sold in October, a number that is likely to grow substantially in the following months as more outlets open their doors (for example, there are 36 licensed marijuana retailers now compared to seven on October 1st).
Continue reading

Dec 21 2022

CBD Associated With Sustained Seizure Reduction in 4-Year Study of Treatment-Resistant Epilepsy

A long-term study of those with treatment-resistant epilepsy has found that the cannabis compound cannabidiol (CBD) is directly associated with a reduction in seizures over a 192-week period.

The study, published by the journal Epilepsia, was conducted by researchers affiliated with the University of Alabama, NYU Langone’s Comprehensive Epilepsy Center, Loma Linda University Children’s Hospital, Augusta University, Nationwide Children’s Hospital, Massachusetts General Hospital and the Idaho Comprehensive Epilepsy Center.

“Cannabidiol (CBD) expanded access program (EAP), initiated in 2014, provided add-on CBD to patients with treatment-resistant epilepsy (TRE) at 35 US epilepsy centers”, states the study. “Prior publications reported results through December 2016; herein, we present efficacy and safety results through January 2019.”
Continue reading

Dec 21 2022

Study Finds Medical Cannabis Improves Sleep in Insomnia Patients

A new randomized, double-blind, placebo-controlled crossover study being published in the upcoming issue of the Journal of Sleep Research has found that medical cannabis improves sleep in those with Insomnia.

The study was conducted by researchers at the National Institute of Integrative Medicine, Torrens University and The University of Adelaide, all in Australia, and was epublished ahead of print on the website for the National Library of Medicine. The study’s full text can be found by clicking here.

Insomnia or difficulty falling and or staying asleep is experienced by up to 30% of the general population, notes the study’s abstract. “This randomised crossover double-blind placebo-controlled 6-week trial aimed to assess the tolerability and effectiveness of the Entoura-10:15 medicinal cannabis oil on sleep in adults with insomnia.”
Continue reading

Dec 21 2022

New York’s First Legal Recreational Marijuana Store Opens December 29

New York Governor Kathy Hochul Announced today that the first licensed recreational marijuana store will open on December 29th.

Governor Kathy Hochul announced today that sales of legal, regulated adult-use cannabis will start on December 29 at a dispensary in Manhattan, operated by Housing Works, the nation’s largest minority-controlled HIV/AIDS service organization and largest community-based HIV/AIDS service organization. The non-profit, based in New York City, operates a range of direct and support services for people living with HIV/AIDS, the homeless, formerly incarcerated, and justice involved individuals. It also operates a network of charitable retail storefronts.

“We set a course just nine months ago to start New York’s adult-use cannabis market off on the right foot by prioritizing equity, and now, we’re fulfilling that goal,” Governor Hochul said. “The industry will continue to grow from here, creating inclusive opportunity in every corner of New York State with revenues directed to our schools and revitalizing communities.”
Continue reading

Dec 20 2022

D.C. Legislation to Expand Medical Marijuana Program Receives Final Council Approval

By a vote of 13 to 0 the Council of the District of Columbia has given final approval to legislation that will significantly expand the district’s medical marijuana program.

The legislation (Bill 24-0113) was introduced by Council Chair Phil Mendelson on behalf of Mayor Muriel Bowser, who is expected to quickly sign it into law now that it has passed the full council.

The proposed law removes the cap on the number of plants that a cultivation center can grow and significantly increases the number of permitted dispensaries in the District. The law also creates new business categories within the industry including on-site consumption facilities and marijuana cooking classes, and it makes permanent the option for patients to self-certify that they’re qualified medical marijuana patients.
Continue reading

Dec 20 2022

Study: CBD May Improve Muscle Recovery

The marijuana compound cannabidiol (CBD) “has the prospective to become an adequate supplement that may improve muscle recovery”, according to a new study epublished by the National Library of Medicine.

The full text of the study, which is published in the December, 2022 issue of the peer-reviewed journal Cannabis and Cannabinoid Research, can be found by clicking here.

“Cannabidiol (CBD), a nonintoxicating constituent of the cannabis plant, recently gained a lot of interest among athletes, since it is no longer considered as a prohibited substance by the World Anti-Doping Agency”, states the study. “The increasing prevalence of CBD use among athletes is driven by a perceived improvement in muscle recovery and a reduction in pain. However, compelling evidence from intervention studies is lacking and the precise mechanisms through which CBD may improve muscle recovery remain unknown.”
Continue reading